LiveSpo Navax® Supports the Treatment of Acute Rhinosinusitis and Otitis Media

Clinical trial NCT05804123 · COMPLETED

Trial details

NCT number: NCT05804123
Sponsor: Anabio R&D
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Upper Respiratory Tract Infections

Start date: 2021-10-28
Primary completion: 2024-04-05
Enrollment: 175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.